Sicherheit & Kontraindikationen

Allgemeiner Haftungsausschluss: Wir informieren über unsere Medizin- und Wellnessgeräte. Obwohl wir unser Bestes tun, um sicherzustellen, dass die Informationen korrekt und informativ sind, ersetzen die Informationen nicht eine professionelle oder medizinische Beratung. Diese Informationen dienen nur allgemeinen Zwecken. Die Bereitstellung dieser Informationen stellt keine Ausübung medizinischer, pflegerischer oder sonstiger professioneller Gesundheitsdienstleistungen, einschließlich der Erbringung medizinischer Beratung, dar. Es kommt kein Arzt-Patienten-Verhältnis zustande. Die Verwendung dieser Informationen oder jeglichen Materials von unserer Website oder Marketingmaterialien basiert auf klinischen Studien, von Experten begutachteten Manuskripten und den Erfahrungen unserer Kunden und ist unter bestimmten Umständen möglicherweise nicht relevant. Dementsprechend sind diese Informationen kein Ersatz für professionelle Beratung, Diagnose oder Behandlung. Benutzer sollten die Einholung ärztlichen Rats für etwaige gesundheitliche Beschwerden nicht außer Acht lassen oder verzögern und sollten bei solchen Beschwerden den Rat ihres medizinischen Fachpersonals einholen.

Bei der Verwendung jeglicher Form der Lichttherapie, einschließlich eines SYMBYX-Geräts, sollten alle Kunden, insbesondere solche mit Komorbiditäten (siehe Tabelle unten), ein gewisses Maß an Vorsicht walten lassen. Kunden können diese Bedingungen auch stillschweigend haben, ohne dass sie davon Kenntnis haben. Es besteht immer das Risiko unerwünschter Nebenwirkungen, einschließlich leichter und vorübergehender Übelkeit, Erbrechen, Schwindel und Schwindel.  Wenn diese Symptome auftreten, warten Sie bitte, bis sie verschwinden Vor Position ändern mit Vorsicht . Es ist wichtig, diese Symptome zu erkennen, die Verwendung Ihres SYMBYX-Geräts sofort einzustellen und bei anhaltenden Symptomen einen Arzt aufzusuchen. Wenn einem Kunden solche Grunderkrankungen bekannt sind, bevor er mit der Lichttherapie beginnt, wird ihm empfohlen, unter klinischer Aufsicht* mit einer ein bis zweiwöchigen Behandlung, also der Hälfte der typischen empfohlenen Dosierung, zu beginnen.

Requirements

Circumstance
Clinical Reasoning

Under medical care for diseases involving photosensitivity or receiving photosensitizing medications

Clinical Reasoning

These medications increase sensitivity to light therapy treatment.

Prescription medications (including for Parkinson’s)*

Clinical Reasoning

SYMBYX devices are designed to complement all pre-existing therapies.

Patients suffering from extreme sensitivity to light (incl vestibular migraine; epilepsy)

Clinical Reasoning

Risk of invoking a deleterious episode.

Pregnancy

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented.

Heart conditions*

Clinical Reasoning

Light therapy might temporarily increase autonomic symptoms, including dizziness, light-headedness, tremor and heart rate. If this happens, patients should immediately contact Clinical Support at clinicalsupport@symbyxbiome.com.

Thrombosis including DVT

Clinical Reasoning

Insufficient supporting evidence, even though no negative episodes have been documented.  

Aneurysms (including intra-cerebral aneurysms and abdominoaortic aneurysms)

Clinical Reasoning

Light therapy might temporarily increase autonomic symptoms, including dizziness, light-headedness, tremor and heart rate. If this happens, patients should immediately contact Clinical Support at clinicalsupport@symbyxbiome.com.

Deep Brain Stimulation (DBS)

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented.

History of acute psychiatric episodes, severe hypermobility (incl Ehlers Danlos); acute polyarthritic disorders*

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented.

Hypermobility and polyarthritic conditions are often accompanied by dysautonomia.

Patient should commence a 1-2 week, half of recommended dosage under clinical supervision*.

Rheumatoid Arthritis*

Clinical Reasoning

Insufficient supporting evidence, even-though no negative episodes have been documented. Patient should commence a 1-2 week, half of recommended dosage under clinical supervision*.

Stroke or history of stroke or transient ischemic attack (TIA)

Clinical Reasoning

Light therapy improves circulation, which may cause further functional or structural deficit.

Tumour site (active primary or secondary)

Clinical Reasoning

Insufficient supporting evidence, even though no negative episodes have been documented. 

Acute head trauma and concussion

Clinical Reasoning

Internal bleeding may develop over the following days and weeks after a head trauma and may be asymptomatic. As light therapy improves circulation, this can cause further functional or structural deficit, even though no negative episodes have been documented.

Migraines*

Clinical Reasoning

Light therapy improves circulation, which may cause further functional or structural deficit during a migraine episode, even though no negative episodes have been documented.

Acute, severe head pain

Clinical Reasoning

Light therapy improves circulation, which may cause further functional or structural deficit during a migraine episode, even though no negative episodes have been documented.

Sunburn

Clinical Reasoning

Light therapy may cause further skin exacerbation.  

* The incidence of dysautonomia is a common complication in several disorders and has been observed in customers suffering from Parkinson’s, migraine, cervicogenic headaches, fibromyalgia, hypermobility syndromes, psychiatric disorders, Irritable Bowel Syndrome, epilepsy, and acute polyarthritic conditions. Symptoms may include dizziness, vertigo, nausea, low blood pressure, and visual disturbances. If dysautonomia symptoms are noted during the initial 2-4 treatments with a SYMBYX device, we recommend ceasing treatment and immediately contacting Clinical Support atclinicalsupport@symbyxbiome.com. Usually, these symptoms are transient and dissipate after a 3-5 day complete rest period, followed by gradual reintroduction of the therapy under clinical supervision. 

** Patient’s with a pacemaker should exercise extra caution and avoid placing the laser over their chest/heart region, even though no negative episodes have been documented. 

***Please do not treat directly over thyroid, glands, genitalia or eyes at any time. There is insufficient supporting evidence for the treatment of these regions.  

Clinical Support Team

Clinical Support Team

Our integrated team of clinicians of physiotherapists and chiropractors provide ongoing advice and support so that you get the most out of SYMBYX light therapy. Find guidance on when, where and precisely how to use the device, with access to an expert whenever you need. Why? Because you believe you deserve more.

REACH OUT TO CLINICAL SUPPORT TODAY

CONTACT THE TEAM TODAY